Artron BioResearch Inc. was founded in Burnaby, British Columbia, Canada in 2002 by a team of talented and experienced
   professionals and scientists. With state-of-art R&D and manufacture facilities, Artron is well known for developing and
   manufacturing, in a large-scale, a great array of high quality antibodies, antigens and critical components of RDT products for
   direct application in lateral flow tests (LFT) (fertility hormones, tumor markers, drugs of abuse, cardiac markers, infectious
   diseases, genetically modified organisms, etc), as well as other applications (chemiluminescence test, ELISA and research-
   based immunoassays).

   In addition, Artron offers the most advanced and cost-effective customized research and development services to design,
   develop, integrate, and validate all aspects of RDT systems.

   As a world class leader in the rapid diagnostic test industry, we are dedicated to bringing innovations into the development of
   protein-based LFT for disease diagnosis and analyte detection.

   Artron is an ISO 13485   certified company and it is committed to helping building up the best
   innovative clinical diagnostics tests across the world.